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Corneodesmosomal Cadherins Are Preferential
Targets of Stratum Corneum Trypsin- and
Chymotrypsin-like Hyperactivity in Netherton
Syndrome
Pascal Descargues1,2, Ce´line Deraison1,2,10, Catherine Prost3,10, Sylvie Fraitag4, Juliette Mazereeuw-
Hautier1,2,5, Marina D’Alessio5, Akemi Ishida-Yamamoto6, Christine Bodemer7, Giovanna Zambruno8 and
Alain Hovnanian1,2,9
SPINK5 (serine protease inhibitor Kazal-type 5), encoding the protease inhibitor LEKTI (lympho-epithelial Kazal-
type related inhibitor), is the defective gene in Netherton syndrome (NS), a severe inherited keratinizing
disorder. We have recently demonstrated epidermal protease hyperactivity in Spink5/ mice resulting in
desmosomal protein degradation. Herein, we investigated the molecular mechanism underlying the epidermal
defect in 15 patients with NS. We demonstrated that, in a majority of patients, desmoglein 1 (Dsg1) and
desmocollin 1 (Dsc1) were dramatically reduced in the upper most living layers of the epidermis. These defects
were associated with premature degradation of corneodesmosomes. Stratum corneum tryptic enzyme (SCTE)-
like and stratum corneum chymotryptic enzyme (SCCE)-like activities were increased, suggesting that these
proteases participate in the premature degradation of corneodesmosomal cadherins. SCTE and SCCE
expression was extended to the cell layers where Dsg1 and Dsc1 immunostaining was reduced. In contrast, a
subset of six patients with normal epidermal protease activity or residual LEKTI expression displayed apparently
normal cadherin expression and less severe disease manifestations. This suggests a degree of correlation
between cadherin degradation and clinical severity. This work further supports the implication of premature
corneodesmosomal cadherin degradation in the pathogenesis of NS and provides evidence for additional
factors playing a role in disease expression.
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INTRODUCTION
Netherton syndrome (NS, OMIM 256500) is a rare autosomal
recessive genodermatosis that combines congenital ichthyo-
siform erythroderma, hair shaft anomalies (trichorrehexis
invaginata), and atopic diathesis (Comel, 1949; Netherton,
1958). The syndrome presents at birth or soon thereafter with
generalized exfoliative erythroderma, which is similar
clinically to other types of infantile erythroderma including
erythrodermic psoriasis, atopic dermatitis, or non-bullous
congenital ichthyosiform erythroderma (OMIM 242100).
Continuous peeling of the skin can persist in NS similarly to
peeling skin syndrome (OMIM 270300) (Schneider et al.,
2000; Sardy et al., 2002). The congenital ichthyosiform
erythroderma-like features can persist throughout life in the
most severe cases or evolve into a unique milder condition
known as ichthyosis linearis circumflexa, consisting of
migratory, serpiginous, and erythematous plaques, which
are bordered by a peculiar double-edged scale (Traupe,
1989). Like ichthyosis linearis circumflexa, trichorrhexis
invaginata (‘bamboo hair’) is pathognomonic for NS and
corresponds to the invagination of the distal part of the hair
shaft into its proximal part (Netherton, 1958; Wilkinson et al.,
1964; Ito et al., 1984). Other hair shaft abnormalities
including pili torti (twisted hair) and trichorrhexis nodosa
(hair of varying diameter) have been reported (Stevanovic,
1969). Affected individuals have a broad range of atopic
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manifestations, including eczema-like rashes, hay fever, and
angio-edema associated with high levels of IgE in the serum
(Judge et al., 1994; Smith et al., 1995). NS patients with
ichthyosis linearis circumflexa have a normal general
development, whereas those presenting generalized exfolia-
tive erythroderma display life-threatening complications such
as hypernatremic dehydration, electrolyte imbalances, hypo-
thermia, failure to thrive, and recurrent infections, resulting in
a high postnatal mortality (Hausser and Anton-Lamprecht,
1996). These complications might be attributed to the severe
alteration of the epidermal barrier function (Fartasch et al.,
1999).
Histopathologic examination of NS skin reveals a ‘psor-
iasiform’ epidermis, which associates hyperplasia of the
subcorneal epithelium (acanthosis) with varying degrees of
epidermal invaginations into the dermis (papillomatosis)
(Hausser and Anton-Lamprecht, 1996). The stratum corneum
often displays persistent nuclei in the cytoplasm of corneo-
cytes (parakeratosis) with a focal absence of the granuler
layer, and can be found detached from the underlying
epidermis or entirely missing (De Wolf et al., 1996; Hausser
and Anton-Lamprecht, 1996; El Shabrawi-Caelen et al.,
2004). Using transmission electron microscopy, lamellar
bodies, which are normally secreted at the transition between
the granular layer and the stratum corneum (Fartasch, 2004),
were seen to be fewer in number and poorly structured. They
are prematurely secreted into the intercellular spaces and
their content remains unprocessed in the basal stratum
corneum (Fartasch et al., 1999). A moderate to severe peri-
vascular inflammatory infiltrate with regions of exocytosis has
been reported in the dermis (Hausser and Anton-Lamprecht,
1996; Sardy et al., 2002).
We previously identified SPINK5 (serine protease inhibitor
Kazal-type 5) as the defective gene in NS (Chavanas et al.,
2000). SPINK5 encodes the multidomain serine protease
inhibitor LEKTI (lympho-epithelial Kazal-type related inhibi-
tor) (Magert et al., 1999), which is expressed in the granular
layer of the epidermis and in the most differentiated stratified
epithelial tissue layers (Bitoun et al., 2003). All SPINK5
mutations identified so far cause premature termination
codons and are associated with complete loss of LEKTI
expression in NS epidermis (Bitoun et al., 2002; Ong et al.,
2004; Raghunath et al., 2004; Sprecher et al., 2004). LEKTI
consists of 15 Kazal-type inhibitory domains, which are
capable of blocking in vitro the activity of a battery of serine
proteases, including trypsin, plasmin, subtilisin A, cathepsin
G, and elastase (Magert et al., 2002; Mitsudo et al., 2003;
Jayakumar et al., 2004).
In order to investigate the biological(s) function of LEKTI,
we have generated and characterized a mouse model for NS.
We demonstrated with this model that unregulated epidermal
protease activities, such as SCTE (stratum corneum tryptic
enzyme) and SCCE-like (stratum corneum chymotryptic
enzyme), result in the degradation of the desmosomal pro-
teins desmoglein 1 (Dsg1) and desmoplakin (Dpk), as well as
enhanced profilaggrin proteolytic processing (Descargues
et al., 2005). Mutant mice with a similar clinical phenotype
have also been developed by others groups (Yang et al.,
2004; Hewett et al., 2005). Our findings are consistent
with the co-localization of LEKTI with SCTE and SCCE in
lamellar bodies in the granular layer (Ishida-Yamamoto et al.,
2005) and the demonstration of elevated levels of trypsin-like
activity in the stratum corneum of patients with NS (Komatsu
et al., 2002). Herein, we have analyzed the molecular
mechanism underlying the epidermal defect in NS. In a
majority of severely affected patients, Dsg1 and desmocollin
1 (Dsc1) expression was decreased in the upper spinous and
granular layers with corneodesmosomes appearing reduced
in size and number in the basal stratum corneum. In these
patients, the activity of stratum corneum tryptic- and
chymotryptic-like enzymes was enhanced, suggesting that
these proteases cause early degradation of corneodesmoso-
mal cadherins in the epidermis of NS patients. In contrast, a
subset of less severely affected patients, two of whom
expressed residual LEKTI levels, showed apparently normal
corneodesmosomal cadherins expression and stratum cor-
neum protease activity. Taken together, these results suggest
that reduced Dsg1 and Dsc1 staining correlates with clinical
severity in NS.
RESULTS
Clinical and molecular features of NS patients
We have examined retrospectively a total of 15 NS patients
from diverse ethnic backgrounds (for details see Materials
and Methods), aged from less than 1 year to 41 years old at
the time of the skin biopsy (Table 1). All patients presented
with the characteristic clinical triad consisting of scaly
erythroderma associated with trichorrhexis invaginata and
atopic manifestations, except for patient 3 who has no scaly
erythroderma. To compare the severity between patients, we
developed a severity score modified from Sprecher et al.
(2001). Patients from nine families (2, 6–11, 13, and 14) have
severe clinical manifestations including generalized skin
involvement with severe hair defect, associated with a history
of failure to thrive and/or growth retardation, hypernatremic
dehydration, and recurrent infections. In the six other families
(1, 3–5, 12, and 15), patients had less severe disease
manifestation with moderate skin involvement and rare
complications. Patient 3 presented with mild skin phenotype
at the time of the skin biopsy, but died during the neonate
period as a result of pulmonary complications. We have
identified at least one mutation in all patients by direct
sequencing of the entire coding sequence of SPINK5
(Table 1). Mutations with their international nomenclature
are shown in Table S1. The mutations were reported
previously for a majority of patients (1–3, 7, 9, 10, 13, and
14) (Chavanas et al., 2000; Bitoun et al., 2002). All mutations
lead to premature termination codons or splice site defects.
Loss of LEKTI expression in the epidermis was found in all
patients (Figure 1d), except for patients 12 and 15. Instead,
these two patients showed a faint and diffuse immunostaining
of LEKTI in the upper spinous and granular layers of the
epidermis (Figure 1e). Only one SPINK5 mutation has been
identified in patient 12 (c.238_239insG), whereas patient 15
is homozygous for c.2579delA. These mutations were
previously reported in other patients in Bitoun et al. (2002)
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and Sprecher et al. (2004), respectively. The c.238_239insG
mutation resulted in a frame shift with a predicted premature
termination codon 18 residues downstream of the mutation
(p.Ala80GlyfsX18). This suggests that the weak immunostain-
ing of LEKTI in the epidermis of patient 12 could be the
consequence of the still unidentified mutation on the second
SPINK5 allele. The c.2579delA mutation localized in exon 27
of SPINK5 leads to a premature codon stop 63 residues
downstream of the mutation (p.Lys860SerfsX63). This in-
dicates that patient 15 with the homozygous c.2579delA
mutation could express a truncated from of LEKTI in the
epidermis. Interestingly, patients 12 and 15 have a less severe
clinical phenotype, with no failure to thrive and no
hypernatremic dehydration (Table 1), suggesting that residual
LEKTI expression in the epidermis could retain some
functional activity, but is not sufficient to prevent the disease.
Alteration of desmosomes ultrastructure in NS epidermis
Transmission electron microscopy examination of the epi-
dermis from seven NS patients (1–3, 9–11, 13, and 15)
revealed pronounced defects. In all patients studied, lamellar
bodies, which are normally secreted at the interface between
the granular layer and the stratum corneum, were prema-
turely fused with the plasma membrane (Figure 2a). They
were secreted into the intercellular spaces of the upper
spinous and granular layers, as reported previously (Fartasch
et al., 1999) (Figure 2a). In these cell layers, lamellar bodies
presented with abnormal morphology as described (data not
shown) (Fartasch et al., 1999). In these patients, the cornified
envelope was prematurely mature in the granular layer as
shown by the increase in the plasma membrane thickness
(Figure 2b). Unprocessed lamellar body-derived sheets and
also intermingled electron-dense material dilated the extra-
cellular spaces of the granular layer (Figure 2b). In this layer,
desmosomes were prematurely changed into corneodesmo-
somes, which are characterized by a well-defined electron-
dense intercellular plug (desmoglea) (Figure 2b). Individual
corneocytes showed numerous lipid droplets (Figure 2c),
undelivered lamellar body discs in the horny cell matrix (data
not shown), nuclear remnants (Figure 2d), and other
Table 1. Clinical and molecular features of NS patients
Skin
involvement
Hair Shaft
abnor-
malities
(TI, PT,
TN)
Serum IgE levels
(IU/mL) Associated Features
1 2 3 1 2 1 24 34
Patient
Age at
biopsy SPINK5 mutations LEKTI ILC
Mild scaly
erythroderma
Generalized
scaly
erythroderma Mild Severe 102–103 103–104 104
Hypernatremic
dehydration
(0/1)
Failure to
thrive
(0/1)
Recurrent
infections
(0/1)
Severity
score
1 1 c.1888-1G4A
(homoz)
 1 1 2 0 0 1 5
2 17 c.2313G4A
(homoz)
 1 3 2 2 1 1 1 11
3 o11 c.153delT (homoz)  1 1 ND 1 1 1 5
4 2 c.2468_2469insA/nd  2 1 1 1 0 1 6
5 17 p.Arg217X/ nd  1 2 1 0 0 1 6
6 o1 c.268_269insT
(homoz)
 3 2 1 1 1 1 9
7 27 c.283-2A 4T/
c.2468_2469insA
 1 3 2 2 ND 1 1 10
8 15 c.238_239insG/ nd  3 2 2 1 1 1 10
9 5 c.1888-1G4A
(homoz)
 3 2 3 0 1 1 10
10 5 c.81+2T4G/
c.153delT
 1 3 1 3 1 1 1 11
11 41 c.1888-1G4A
(homoz)
 3 2 3 1 ND 1 10
12 21 c.238_239insG/nd + 2 1 2 0 0 1 6
13 27 c.238_239insG/
p.Arg217X
 3 2 3 1 1 1 11
14 12 c2041_2042del/
p.Arg371X
 1 3 2 2 1 1 0 10
15 3 c.2579delA (homoz) + 2 1 2 0 0 0 5
homoz, homozygous; IgE, immunoglobulin E; ILC, ichthyosis linearis circumflexa; ND, not determined; PT, pili torti; SE, scaly erythroderma at birth; TI,
trichorrhexis invaginata; TN, trichorrhexis nodosa.
1The patient died during the neonate period as a result of pulmonary complications, with minimal skin involvement.
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inclusions. In addition to these anomalies, intercellular splits
could be found in some patients, at the transition between the
granular layer and the stratum corneum (Figure 2c) or in the
lower stratum corneum (Figure 2d). Interestingly, corneodesmo-
somes appeared considerably altered, with degradation of the
desmoglea (Figure 2e), in the lower stratum corneum for all
the patients analyzed, except for patient 15 (Figure 2c and d).
Monitoring of corneodesmosomes properties at the granular
layer and stratum corneum interface revealed a significant
reduction (28%) in their number in the epidermis of NS
patients in comparison with controls (Table S2). The average
corneodesmosome size was also diminished by 37% in the
epidermis of patients with NS, compared to controls (Table
S2). A minority of patients showed altered desmosomes in the
upper spinous and granular layers with dilation of inter-
cellular spaces (Figure 2f). Microsplits were also occasionally
observed for these patients in the lower granular layer (Figure
2g) with desmosomes associated entirely with one of the two
cells and not split in half (Figure 2h). Anomalies of
(corneo)desmosome ultrastructure and number were not
observed in the epidermis of patients with other keratinizing
disorders, including lamellar ichthyosis (two cases), ichthyo-
sis vulgaris (one case), and psoriasis (one case) (data not
shown). For these patients, no split could be seen at the
transition between the stratum corneum and the granular
layer or in the lower stratum corneum (data not shown). All
together, these results indicate that premature degradation of
Normal
Normal NS NS
Hf
NS
a b
c d e
Figure 1. Histopathology of NS epidermis. (a) Hematoxylin–eosin staining
shows a normal epidermis with approximately a thickness of five cell layers in
the stratum Malpighi (living cell layers) and the characteristic basket wave
conformation of the stratum corneum. (b) NS patient epidermis shows an
increased epidermal thickness (acanthosis) and marked invagination of the
epidermis into the dermis (papillomatosis). The stratum corneum is lacking on
the right side of the picture and is replaced by parakeratotic cells (corneocytes
with persistent nuclei) on the left side. The granular layer is focally present in
the epidermis of the NS patient on the right side of the picture and is lacking in
the region with parakeratosis. Immunohistochemical staining of paraffin-
embedded sections with anti-LEKTI D1–D6 monoclonal antibody showing
that LEKTI is mainly expressed in the (c) granular layer in normal epidermis
and is absent in the (d) epidermis of NS patients, as shown previously (Bitoun
et al., 2003). (e) In contrast, patient 15 displays a faint and diffuse
immunostaining of LEKTI in the upper spinous and granular layers as well as
in the inner root sheath of hair follicles. Hf: hair follicle. Scale bar: 50 mm.
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Figure 2. Ultrastructure analysis of NS epidermis. In normal epidermis,
exocytosis of lamellar bodies was completed at the interface between the
granular layer and the stratum corneum (data not shown). (a, arrow) In the
epidermis of NS patients, lamellar bodies are prematurely fused with the
plasma membrane of keratinocytes in the granular layer and are secreted into
the intercellular spaces. (b) In the granular layer of the epidermis of patient
with NS, the plasma membrane is thicker (arrows), suggesting accelerated
maturation of the cornified envelope. (b, open arrowheads) Unprocessed
lamellar body sheets dilate the extracellular spaces of the overlying granular
layer. (b, open arrows) In this same layer, desmosomes are prematurely
transformed into corneodesmosomes with well-defined electron-dense plugs
corresponding to the reinforcement of the desmoglea. In the stratum corneum,
the cytoplasm of the corneocytes contains numerous (c, arrows) lipid droplets
and (d, star) nuclear remnants. (c and d, open arrows) At the interface
between the granular layer and the stratum corneum, or in the lower stratum
corneum, splits can be seen with partial or complete loss of corneodesmo-
somes, (e, arrow) as a consequence of a premature degradation of the
extracellular plug (desmoglea). (e, open arrow) Note the presence of lamellar
sheets surrounding the corneodesmosome remnant. (f) In the upper spinous
and granular layers, some desmosomes show abnormal ultrastructure
associated with the dilation of the intercellular space. (g) Micro-splits
can be occasionally found with (h) desmosomes associated entirely with
one of the two cells . SC: stratum corneum; GR: granular layer. Scale bars:
(a) 0.1mm; (b) 1 mm; (c) 3.3mm; (d) 1.4 mm; (e) 0.2mm; (f) 0.1mm; (g) 1.4 mm;
and (h) 0.25 mm.
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corneodesmosomes and splits formation could be a unique
feature of the NS epidermis.
Abnormal expression of epidermal terminal differentiation
markers reveals premature cornification
We investigated the expression of epidermal terminal
differentiation markers including involucrin, loricrin, and
filaggrin in the epidermis of patients with NS. Involucrin,
which is an early marker of cornification, was expressed in
the upper spinous layer and in the granular layer of normal
epidermis (Figure 3a). In NS epidermis, involucrin was
slightly overexpressed in the same layers (Figure 3b). Loricrin,
a much later marker of cornification, was restricted to the
upper granular layer in normal epidermis (Figure 3c). Its
staining was markedly increased and diffused in the
cytoplasm of keratinocytes in the superficial spinous and
granular layers of NS epidermis (Figure 3d). Abnormal
expression of involucrin and loricrin was observed in a
majority of patients analyzed. Filaggrin, which is mainly
present in the stratum corneum of normal epidermis, showed
a discontinuous pattern in the stratum corneum of NS patients
(Figure 3f).
Reduction of desmosomal proteins staining in the granular layer
We have analyzed the expression of the major desmosomal
components including Dsg1 and -3, Dsc1 and -3, Dpk,
plakoglobin, and corneodesmosin (CDSN). As shown pre-
viously, Dsg1 and Dsc1 expression were restricted to the
upper spinous and granular layers in normal epidermis
(Figure 4a and c). In the epidermis of NS patients, Dsg1
was present in the suprabasal cell layer, but was markedly
reduced or absent in the upper spinous and granular layers of
the epidermis in nine patients (1,2, 7–11, 13, and 14) (Figure
4b). Anti-Dsc1 staining was also diminished in these layers in
the epidermis of six patients (2, 8–11, and 13) (Figure 4d).
Dsg3 and Dsc3 staining predominated in the basal layer of
normal epidermis and extended to almost all epidermal cell
layers (Figure 4e and g). In the epidermis of NS patients, these
two desmosomal proteins were redistributed to suprabasal
layers, leaving the uppermost part of the acanthotic epidermis
unstained (Figure 4f and h). DP, which is a constitutive
desmosomal component linking desmosomes to the cyto-
skeleton, was expressed in all the layers of normal and NS
epidermis (Figure 4i), but was reduced in the upper spinous
and granular layers in three NS patients (8, 10, and 11)
(Figure 4j). Interestingly, desmosomal protein expression
(Dsg1, Dsc1, and DP) was normal in patients 12 and 15
who showed moderate LEKTI expression (data not shown).
Plakoglobin, which is a component of both desmosomes and
adherents junctions, showed no obvious anomalies in NS
epidermis when compared with control samples (data not
shown). CDSN, which is incorporated into the extracellular
core domain (desmoglea) of desmosomes at the transition
between the granular layer and the stratum corneum, was
expressed in the upper granular layer in normal epidermis
(Figure 4k). This protein was overexpressed in the upper
spinous and granular layers up to the stratum corneum in the
epidermis of eight NS patients for which Dsg1 staining was
decreased (Figure 4l). CDSN immunostaining was mainly
polarized at the upper periphery of the keratinocytes in the
epidermis of patient with NS (Figure 4l). The anomalies of
Dsg1 and Dsc1 expression described above were not
observed in the pathological epidermis of patients with
psoriasis, atopic dermatitis, or lamellar ichthyosis (9, 4, and 5
cases analyzed, respectively) (data not shown).
Redistribution of the epidermal proteases SCTE and SCCE and
proteinase-activated receptor-2
We have analyzed the expression of SCTE and SCCE, two
major serine proteases involved in the desquamation process
through the degradation of desmosomal proteins in the lower
layers of the stratum corneum in normal epidermis. In
controls, both SCTE and SCCE were expressed in the stratum
corneum and also at the transition between the granular layer
and the stratum corneum (Figure 5a and e). Of the nine NS
patients with reduced Dsg1 expression, four patients (9, 11,
Normal
Inv
Normal
Lor
Normal
FG FG
NS
Lor
NS
Inv
NS
a b
c d
e f
Figure 3. Immunohistochemistry of epidermal terminal differentiation
markers. (a, b) Distribution of involucrin, a major precursor of the cornified
envelope, in the epidermis of normal control and NS patient showing
expression in the upper spinous and granular layers in both cases, but with a
moderate increase in NS patient skin. (c, d) Loricrin staining is more intense in
the granular and the upper spinous layers of the epidermis of NS patient
epidermis compared with that of normal skin. (e, f) Filaggrin shows a
discontinuous expression in the stratum corneum of NS patients, the intensity
of which is comparable with those seen in normal stratum corneum. Scale
bar: 50 mm.
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13, and 14) showed redistribution of SCTE immunostaining at
the periphery of keratinocytes in the upper spinous and
granular layers (Figure 5b). Interestingly, SCTE staining
matched the cell layers where Dsg1 expression was reduced
(Figure 5c and d). Redistribution of SCCE was also seen in the
upper spinous and granular layers in five of the nine patients
mentioned above (8–10, 13, and 14) (Figure 5f). In contrast,
none of the patients with apparently normal Dsg1 expression
showed abnormal expression of SCTE or SCCE (data not
shown). We next studied the expression of the protease-
activated receptor 2 (PAR2), a receptor that can be activated
by trypsin-like proteases and which is involved in skin
Normal
Dsg1
Normal
Dsc1
NS
Dsc1
NS
Dsg1
Normal
Dsg3
Normal
Dsc3
NS
Dsc3
NS
Normal
DP DP Cdsn Cdsn
Normal NSNS
Dsg3
a b c d
e f g h
i j k l
Figure 4. Immunodetection of epidermal desmosomal components. (a, c) Dsg1 and Dsc1 are expressed in the upper spinous and granular layers of normal
epidermis. (b) The cell surface staining of Dsg1 is detectable in the suprabasal epidermis, but is remarkably reduced or absent in the upper spinous and granular
layers of NS patient epidermis. (d) Similarly, Dsc1 immunostaining is also decreased in these cell layers. (e and g) Dsg3 and Dsc3 staining is mainly seen in the
basal layer of normal epidermis and extended to almost all epidermal cell layers. (f and h) In the epidermis of NS patients, these two desmosomal proteins were
redistributed to suprabasal layers, leaving the uppermost part of the epidermis unstained. DP detection, a component of the desmosomal plaque expressed in
(i) all cell layers of normal epidermis, is also decreased in the (j) granular layer of NS epidermis . CDSN expression is increased and extended to the (k)
upper spinous and granular layers of NS patient epidermis, compared to its expression in the (l) stratum corneum and the granular layer of normal epidermis.
Scale bar: 50 mm.
Normal
SCTE
SCCE SCCE PAR2 PAR2
SCTE
NS
SCTE
NS
Dsg1
NS
Normal NS Normal NS
a b c d
e f g h
Figure 5. Immunohistochemical analysis of stratum corneum proteases and proteinase-activated receptor-2. (a) Anti-SCTE staining shows a restricted
distribution of this protease in the stratum corneum and at the interface with the underlying granular layer in normal epidermis. SCTE is slightly increased
in the (b, c) stratum corneum of NS patients and is focally expressed at the (b, c) cell surface of several cell layers just beneath the stratum corneum including
the upper spinous and granular layers. Remarkably, the extension of SCTE labeling correlates with the cell layers in which Dsg1 staining is reduced (compare c
with d). SCCE is mainly present in the (e) lower stratum corneum in normal epidermis, whereas its expression is also detected in the (f) upper spinous and
granular layers in NS patient epidermis. PAR2 cytoplasmic staining is present in an increased number of cell layers in the (h) upper spinous and granular layers in
the epidermis of patients with NS, in comparison with its distribution restricted to the (g) upper granular layer in normal epidermis. Scale bar: 50 mm.
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inflammation. In normal epidermis, PAR2 immunostaining
was cytoplasmic and restricted to the granular layer
(Figure 5g). In all NS patient epidermis studied (7–14),
PAR2 staining was seen in an increased number of cell
layers, spanning from the upper spinous layer to the granular
layer (Figure 5h).
Enhanced stratum corneum trypsin- and chymotrypsin-like
activity in NS patients
We next assessed whether the diminished corneodesmosome
density and desmosomal protein expression in the upper
spinous and granular layers resulted from enhanced epider-
mal protease activity in seven NS patients (2–4, 6, 11, 13, and
15). In situ zymography using casein conjugated to FITC as a
substrate showed that protease activity was markedly
increased in the epidermis of three NS patients (2, 11, and
13) in comparison with normal epidermis (Figure 6a and b).
This enzymatic activity mainly localized to the stratum
corneum (Figure 6b). We used a preferential substrate of
SCTE to evaluate the in situ trypsin-like activity of the
epidermis from seven NS patients. In normal epidermis,
trypsin-like hydrolytic activity mainly localized to the stratum
corneum and could be attributed to SCTE-like activity (Figure
6d). SCTE-like activity was increased in the stratum corneum
of the epidermis in patients 2, 11, and 13 (Figure 6e). In situ
zymography was also performed with a preferential substrate
of SCCE showing that SCCE-like activity was present,
although weak, in the stratum corneum of normal epidermis
(Figure 6g). SCCE-like activity was markedly increased in the
stratum corneum of patients 2, 11, and 13 (Figure 6h).
Interestingly, increased SCTE- and SCCE-like activity in the
stratum corneum of NS patients 2, 11, and 13 coincided with
the diminution of Dsg1 and Dsc1 expression in the upper
spinous and granular layers. In the four other NS epidermis
analyzed (3, 4, 6, and 15), protease activity was not
enhanced, and expression of these desmosomal cadherins
was normal.
DISCUSSION
In this study, we provide evidence that the absence of LEKTI
expression in NS results in enhanced SCTE- and SCCE-like
activity with premature degradation of corneodesmosomes in
the lower stratum corneum. In the epidermis of patients with
NS, corneodesmosomes displayed abnormal ultrastructure
with alteration of the well-defined electron-dense plugs, as
seen in the upper stratum compactum of normal epidermis,
where loss of cohesion between corneocytes leads to
desquamation (Fartasch et al., 1993). These defects are
associated with a reduction of Dsg1 and Dsc1 immunostain-
ing in the uppermost living layers of the most severely
affected NS patients. This reduction is likely to result from an
abnormal degradation of these desmosomal cadherins by the
unregulated SCTE- and SCCE-like activity. The redistribution
of SCTE and SCCE immunostaining in the cell layers in which
Dsg1 and Dsc1 staining was reduced supports this hypoth-
esis. However, increased proteolytic activity was not dete-
cted in these cell layers, suggesting a possible role of other
proteases in desmosomal proteins premature degradation.
Taken together, these results are consistent with the recent
demonstration that Spink5/ mice reproduce the NS pheno-
type through the degradation of Dsg1 by epidermal proteases
(Descargues et al., 2005).
The SCTE and SCCE serine proteases, two members of the
kallikrein family (klk5 and klk7, respectively), are major
regulators of the desquamation process (Hansson et al., 1994;
Ekholm et al., 2000), and are expressed in the granular layer
of normal epidermis (Ishida-Yamamoto et al., 2005). In vitro
studies have demonstrated that SCTE degrades both Dsg1 and
Dsc1, whereas SCCE cleaves only Dsc1 (Caubet et al., 2004).
These results are strongly concordant with the reduction of
desmosomal cadherins staining in the granular layer and the
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Figure 6. In situ zymography analysis. (a) In normal epidermis, total protease
activity detected by the degradation of the BODIPY FL casein substrate is
mainly found in the stratum corneum. (b) In the epidermis of patient 13 with
NS, the caseinolytic activity is increased in the stratum corneum. (c, d)
Trypsin-like activity shown by cleavage of the synthetic peptide Boc-Val-Pro-
Arg-AMC is increased in the stratum corneum of patient 13 in comparison
with normal epidermis. (e, f) Incubation of frozen skin sections with Suc-Leu-
Leu-Val-Tyr-AMC peptide solution reveals that chymotrypsin-like activity is
also markedly enhanced in the stratum corneum of patient 13, compared with
a normal control. The color gradient represents the intensity values of the
fluorescence signals ranging from 0 (dark) to 255 (white). Scale bar: 50 mm.
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increased activity of SCTE- and SCCE-like enzymes in the
stratum corneum of NS patients that we report. As LEKTI can
inhibit both SCTE and SCCE in vitro (Egelrud et al., 2005;
Schechter et al., 2005), loss of LEKTI expression in NS
epidermis could result in an unregulated activity of these two
proteases, with a consequent degradation of Dsg1 and Dsc1.
Other trypsin-like proteases that are members of the kallikrein
family (klk1, klk4, klk6, klk9–11, klk13, and klk14) are also
expressed in the granular layer of normal epidermis (Yousef
and Diamandis, 2001; Komatsu et al., 2003, 2005). There-
fore, the enhanced trypsin-like activity in the stratum
corneum of NS patients could also be attributed to other
unregulated proteases.
Whereas epidermal desmosomes contain four isoforms of
Dsgs and three isoforms of Dscs, corneodesmosomes contain
only Dsg1 and Dsc1 isoforms (Yin and Green, 2004).
Therefore, premature degradation of these two cadherins in
the epidermis of NS patients by SCTE- and SCCE-like
proteases could well result in the loss of stratum corneum
integrity and split formation. These anomalies could account
for the severe skin barrier defect observed in NS patients and
their propensity to develop hypernatremic dehydration
(Moskowitz et al., 2004).
Out of the 15 patients studied, six patients (3–6, 12, and
15) presented with normal Dsg1 and Dsc1 immunostaining in
the epidermis. SCTE or SCCE immunostaining were also
distributed normally in the stratum corneum of these patients.
In patients 12 and 15, residual LEKTI expression could in part
inhibit epidermal serine proteases activity and prevent
premature proteolysis of Dsg1 and Dsc1. This could account
for limited corneodesmosome alterations as seen in patient
15, and for a less severe clinical phenotype. The other four
patients (3–6) with normal Dsg1 and Dsc1 expression
displayed SCTE- and SCCE-like activity in the stratum
corneum, equivalent to that detected in normal skin.
Interestingly, three of these patients (3–5) showed a mild to
moderate cutaneous phenotype at the time of the biopsy.
These results suggest that in the absence of LEKTI, the activity
of the stratum corneum proteases could be attenuated by
other skin-derived protease inhibitors, such as SKALP (skin-
derived antileukoprotease) (Franzke et al., 1996), which has
been shown to be overexpressed in the epidermis of NS
patients (Raghunath et al., 2004; Shimomura et al., 2005) and
SLPI (secretory leukocyte protease inhibitor), which is also
present in the epidermis (Franzke et al., 1996; Magert et al.,
2005).
Several defects seen in NS patients are concordant with
the alteration of the keratinization process, which is a
characteristic feature of NS (Hausser and Anton-Lamprecht,
1996). The defective skin barrier function, resulting from the
loss of stratum corneum integrity, could result in typical
compensatory mechanisms of adult epidermis. These include
abnormal differentiation as well as hyperproliferation, ac-
counting for acanthosis, and hyperkeratosis (Elias, 2005). The
degradation of the desmosomal cadherins in the granular
layer of the epidermis in NS patients coincides with CDSN
overexpression. This glycoprotein, which is normally incor-
porated into the extracellular part of corneodesmosomes, has
been hypothesized to stabilize them and to shield Dsg1 and
Dsc1 from premature proteolysis (Serre et al., 1991;
Lundstrom et al., 1994; Simon et al., 1997). CDSN could
also be a target for both SCTE and SCCE (Caubet et al., 2004),
but its overexpression in NS epidermis has precluded precise
analysis of its proteolysis.
Serine proteases can mediate specific regulatory effects via
proteinase-activated receptors (PARs). Among the four PARs
currently known (PAR1–4), PAR2 is of particular interest as it
has been localized to the granular layer of the epidermis
(Steinhoff et al., 1999) and is overexpressed in atopic
dermatitis (Buddenkotte et al., 2005). Interestingly, PAR2 is
also overexpressed in the upper spinous and granular layers
of the epidermis in NS patients. In the absence of LEKTI
expression, uncontrolled activity of SCTE and/or SCCE may
lead to an overactivation of PAR2, as this receptor can be
activated by various trypsin-like proteases (Coughlin and
Camerer, 2003). As PAR2 is involved in keratinocyte
differentiation and proliferation (Santulli et al., 1995; Derian
et al., 1997), as well as skin inflammation (Coughlin and
Camerer, 2003), its overactivation may contribute to the skin
defect observed in NS.
In conclusion, our findings indicate that unregulated
desquamation plays a major role in the disease mechanism
of NS. In a majority of patients, staining of Dsg1 and Dsc1 is
reduced and stratum corneum tryptic- and chymotrytic-like
enzyme activity are enhanced. These patients are severely
affected with a pronounced barrier abnormality and a marked
propensity for hypernatremic dehydration (Moskowitz et al.,
2004). Others NS patients do not display these abnormalities
and are less severely affected, indicating that the level of
LEKTI expression and others factors could play a role in
disease expression. These results designate SCTE and SCCE as
key players in the diseases process. They also indicate that
specific inhibitors of these enzymes have the potential to
compensate for LEKTI deficiency and thus could constitute a
powerful therapeutic approach to restore epidermal integrity
and barrier permeability in NS.
MATERIALS AND METHODS
Patients and clinical material
We ascertained 15 NS families including 15 patients with NS, with
their informed consent. Parental consanguinity was known for six
patients (1–3, 9, 10, and 15). Patients originated from Europe
(France, Italy, and Kosovo) and North Africa (Morocco and Mali).
Patient ages ranged from newborn to 41 years old at the time of
biopsy and clinical examination. The diagnostic of NS was based on
family history and clinical examination according to the following
parameters: (i) scaly erythroderma in the first year of life, (ii)
ichthyosis linearis circumflexa; (iii) hair shaft defect including
trichorrhexis invaginata, and (iii) atopic manifestations (IgE serum
levels) (Table 1). Extracutaneous involvement was also recorded. To
compare the severity between individuals, we developed a severity
score (Table 1) based on the following criteria: skin involvement
(ichthyosis linearis circumflexa¼ 1, mild scaly erythroderma¼ 2,
generalized scaly erythroderma¼ 3); hair shaft anomalies (mild¼ 1,
severe¼ 2); IgE levels (102–103 IU/ml¼ 1, 4103–104 IU/ml¼ 2,
410,000 IU/ml¼ 3), and associated features (absent¼ 0,
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present¼ 1). Mutations were identified for these patients by direct
sequencing of the coding region of SPINK5 as reported previously
(Bitoun et al., 2002). The medical ethical committee CCPPRB
(Comite´ consultatif de protection des personnes se preˆtant a` des
recherches biome´dicales) of Toulouse hospitals approved all
described studies (Research Project No. 0102908). The study was
conducted according to the Declaration of Helsinki Principles and
patients gave their written informed consent.
Histopathology
Light microscopy analysis of the epidermis from the 15 NS patients
showed numerous abnormalities in comparison with normal
epidermis (Figure 1a and b). A marked acanthosis associated with
papillomatosis was a constant feature. The stratum corneum was
often parakeratotic in NS patients (11 patients out of 15) and
hyperkeratosis (increased thickness of the stratum corneum) could be
detected in seven patients (6 and 9–14). The granular layer was often
mostly diminished in NS epidermis or completely lacking in regions
with parakeratosis. A marked hypergranulosis was seen in the
epidermis of patients 9 and 14 in association with hyperkeratosis
of the stratum corneum without parakeratosis. Only a minimal
to moderate inflammatory infiltrate, mostly consisting of mono-
nuclear cells, was present in the papillary dermis of a majority
of patients.
Transmission electron microscopy
Small pieces of skin samples were fixed in 4% glutaraldehyde with
0.1 phosphate (Sorensen’s) buffer, pH 7.4, for 1 hour at 41C, and
rinsed twice in Sorensen’s buffer, pH 7.4, for 12 hours at 41C. They
were subsequently post-fixed for 1 hour at room temperature in
0.25 M saccharose with 0.5 M Sorensen’s buffer and 2% osmium. The
samples were then dehydrated in a graded series of ethanol solutions
and embedded with the Embed 812 kit (Electron Microscopy
Sciences, Hatfield, PA). ‘Near-surface’ sections (80–90 nm) were
mounted on copper grids, stained with uranyl acetate and lead
citrate, and examined with a transmission electron microscope.
Corneodesmosome properties were analyzed as follows: total
individual corneodesmosomes were quantified at electron micro-
scopy magnification ( 15,000) at the granular layer and stratum
corneum interface, and factorized by total continuous membrane
length previously normalized against scale bar within each image.
Individual corneodesmosome length along the plasma membrane at
the granular layer and stratum corneum interface was also measured.
The statistical significance of differences between groups (normal
and NS) of continuous variables was analyzed using the Mann–
Whitney U-test.
Antibodies
Primary antibodies were directed against: involucrin, SCCE, and
Dsg1 (Santa Cruz Biotechnology, Santa Cruz, CA); loricrin and
filaggrin (Covance Research Products, Denver, PA); Dsg3 and
plakoglobin (Zymed Laboratories, South San Francisco, CA); Dsc1
and -3 (Progen, Deutschland); DP (Serotec, UK); and SCTE (Abcam,
UK). These antibodies were used following the manufacturer’s
recommendations. The anti-CDSN polyclonal antibody was gener-
ated by Dr A. Ishida-Yamamoto (Department of Dermatologie,
Midorigaoka Medical College, Asahikawa, Japan) and was raised
against the central part (AAGPPISEGKYFSS) of the CDSN protein.
This antibody, as well as the anti-LEKTI D1-D6 monoclonal
antibody, was used as previously reported in Descargues et al.
(2005) and Bitoun et al. (2003), respectively. The anti-PAR2 A5
polyclonal antibody was a generous gift from Dr N. Vergnolle and
Dr M.D. Hollenberg (Department of Pharmacology and Therapeu-
tics, University of Calgary, Calgary, Canada). This antibody was
raised against a peptide sequence derived from the N-terminus of the
mouse PAR2 protein (GPNSKGRSLIGRLDTPYGGC) and was used at
the dilution of 1:1,000 onto paraffin-embedded sections.
Histology and immunohistochemistry
Skin biopsies were fixed for 24 hours in 10% neutral-buffered
formalin, dehydrated for 24 hours in 70% ethanol, and embedded in
paraffin. Four-micrometer sagittal sections were cut and stained with
hematoxylin and eosin. For immunohistochemical analysis, the
reactivity to various antibodies was investigated with the 4 mm
sections. A specific signal was detected using the appropriate Dako
EnVision System, HPR (DAB) kit (Dako, Denmark).
In situ zymography
Frozen sections (5mm thickness) were rinsed with a washing solution
(2% Tween 20 in deionized water) and incubated at 371C overnight
with 100ml of BODIPY FL casein using the EnzChek Ultra Protease
Assay kit (Invitrogen, Carlsbad, CA) in deionized water (10 mg/ml) in
order to visualize global protease activity. Cryostat sections were
incubated in the same conditions with 100ml of Boc-Val-Pro-Arg-
AMC or Suc-Leu-Leu-Val-Tyr-AMC (Sigma-Aldrich, St Louis, MO) at
100mM in Tris 50 mM, CaCl2 10 mM for the detection of trypsin- and
chymotrypsin-like activity, respectively. All sections were rinsed
with the washing solution, mounted, and visualized with the
inverted high-end microscope Axiovert 200 (Zeiss, UK) at an
excitation wavelength of 485 and 400 nm and an emission
wavelength of 530 and 460 nm for BODIPY FL and AMC fluorescent
dyes, respectively. Frozen sections from normal and NS skin were
photographed at equal time points and exposure time. The
specificity of the fluorescence signal was controlled by incubating
frozen sections with 1 mM of serine protease inhibitor AEBSF (Sigma-
Aldrich, St Louis, MO). Images were captured and analyzed with
Metamorph Imaging system software, version 3.6 (Universal Imaging
Corporation, Downingtown, PA). The intensity of the fluorescence
signals was coded as color gradient, ranging from 0 (dark) to 255
(white).
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